Lonza lends support to innovation clusters in France and Italy

Published: 10-Dec-2014

Gains easier access to potential in-licensing of new technologies and products


Switzerland-headquartered Lonza is to work with two innovation clusters in France and Italy to help support small biotechnology companies that are developing novel therapeutics.

Medicen Paris Region is one of Europe’s biggest life sciences and healthcare clusters and aims to highlight and reinforce the Paris Region as Europe's leading industrial centre for medical devices innovations and health technologies.

BioPmed Innovation Cluster in the Piemonte region of Italy promotes and develops the use of different technological solutions from many companies to address unmet medical needs.

Lonza will not only offer cluster members technical presentations and workshops on specific Lonza technologies and share its expertise and experience in a range of early-stage product development topics, but it will also gain access to potential technology in-licensing opportunities.

'These collaboration agreements will benefit Lonza by giving us a better understanding of the mid- and long-term strategies of the biotech industry in Europe,' said Anne Hays, Head of Lonza’s Custom Development Services Organisation.

'We will also get an early look at potential technology in-licensing opportunities and learn about new therapeutic and technological developments to benefit patients.'

Relevant companies

You may also like